Long-term Remissions Following CD20-directed Chimeric Antigen Receptor Adoptive T cell Therapy.
Mo G, Lee SY, Coffey DG, Voillet V, Kirsch IR, Gottardo R, Smythe KS, Yeung CCS, Greenbaum A, Green DJ, Maloney DG, Till BG.
Mo G, et al. Among authors: coffey dg.
Blood Cancer Discov. 2024 May 15. doi: 10.1158/2643-3230.BCD-23-0263. Online ahead of print.
Blood Cancer Discov. 2024.
PMID: 38747505